
Dr Sara El Hoss
Marie Sklodowska Curie Post-Doctoral Fellow
Biography
After obtaining her PhD from the University of Paris, Dr El Hoss was awarded a Marie Sklodowska Curie Postdoctoral Research Fellowship for conducting her postdoctoral research in the Red Cell Hematology Laboratory at King’s College London. Dr El Hoss has made important contributions to the understanding of the pathophysiology of sickle cell disease (SCD) and her research has notably evidenced that ineffective erythropoiesis is a hallmark of SCD. Her current research focuses on understanding the molecular mechanisms of ineffective erythropoiesis in SCD with the aim of developing new therapeutic approaches that could ameliorate this altered process in patients. Together with clinician colleagues and research collaborators, she is also developing a red cell platform that will be used to investigate red cell properties in health and disease at KCL that will be part of the translational sickle cell disease research program headed by Pr. Strouboulis.
Research

Prenatal ThERapy for SIckle CelL disEaSe (PERICLES)
To generate new knowledge about stakeholders' views on prenatal therapy for Sickle Cell Disease, identify ethical issues and establish protocols for support.
Project status: Ongoing
News
New research investigates differences in sickle cell disease between the sexes
An in-depth analysis as to why people of the female sex may have milder symptoms for sickle cell disease could provide a better understanding of these...

Research

Prenatal ThERapy for SIckle CelL disEaSe (PERICLES)
To generate new knowledge about stakeholders' views on prenatal therapy for Sickle Cell Disease, identify ethical issues and establish protocols for support.
Project status: Ongoing
News
New research investigates differences in sickle cell disease between the sexes
An in-depth analysis as to why people of the female sex may have milder symptoms for sickle cell disease could provide a better understanding of these...
